Institutional investors

Financial Intermediaries – Apply here

Disclaimer: the call for expression of interest is not intended to be a marketing communication addressed to investors or potential investors, within the meaning of the ESMA guidelines on marketing communications under the Regulation on cross-border distribution of funds. The call for expression of interest is an informative document targeting potential financial intermediaries only. Potential eligible investors should not rely on the call for expression of interest to invest in SDUF but refer to the private placement memorandum of SDUF before making any investment decision.

Financial intermediaries interested in receiving an investment from SDUF under the Health Compartment can apply following the Call for Expression of Interest published below.

Please download the documents, carefully check the criteria and details, and submit the Expression of Interest duly filled in by the deadline. The completed Expression of Interest may be accompanied by additional information you deem relevant to sustaining the application documentation.

After applying, you will have to be pre-selected before the EIF sends the proposal further in the approval process. We select financial intermediaries according to a standard process involving due diligence and proof of compliance with relevant standards and legislation.

The final selection of financial intermediaries will be made by the SDUF Investment Committee based on the recommendations of the EIF as an adviser, following the completion of the assessment for the selection process.

Deadline for submitting your Expression of Interest to the EIF:
30 September 2023 (date of receipt)

• Call for Expression of Interest   
• Annex I – Expression of Interest DOC | PDF
• Annex II – Investment Guidelines
• Annex III – Guidelines for the VCoE

The SDUF Health Compartment supports the European life science sector and provides the framework for strategic collaborations among stakeholders in the pharma sector, including venture capital funds and life science companies.

The initiative is supported by European Union through a cornerstone commitment of up to EUR 150 million under the European Fund for Strategic Investments (EFSI), and also entails a cooperation between the EIF and EIT Health.